Cargando…
Atrial fibrillation in cardiac resynchronization therapy
Patients with atrial fibrillation (AF) were largely excluded from the major clinical trials of cardiac resynchronization therapy (CRT), despite the presence of AF in up to 40% of patients receiving CRT in clinical practice. AF appears to attenuate the response to CRT, by the combination of a reducti...
Autores principales: | Elliott, Mark K., Mehta, Vishal S., Martic, Dejana, Sidhu, Baldeep S., Niederer, Steven, Rinaldi, Christopher A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710632/ https://www.ncbi.nlm.nih.gov/pubmed/34988530 http://dx.doi.org/10.1016/j.hroo.2021.09.003 |
Ejemplares similares
-
Ablation as First-line Therapy for Atrial Fibrillation
por: Andrade, Jason G
Publicado: (2023) -
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation
por: Andrade, Jason G, et al.
Publicado: (2022) -
Gut Microbiota and Atrial Fibrillation: Pathogenesis, Mechanisms and Therapies
por: Al-Kaisey, Ahmed M, et al.
Publicado: (2023) -
Atrial Fibrillation in Congenital Heart Disease
por: Martín de Miguel, Irene, et al.
Publicado: (2021) -
Neuromodulatory Approaches for Atrial Fibrillation Ablation
por: Rodríguez-Mañero, Moisés, et al.
Publicado: (2021)